Compare KEX & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KEX | AMRX |
|---|---|---|
| Founded | 1921 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 6.4B |
| IPO Year | 1994 | 2018 |
| Metric | KEX | AMRX |
|---|---|---|
| Price | $136.41 | $19.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $169.00 | $22.71 |
| AVG Volume (30 Days) | 448.5K | ★ 2.7M |
| Earning Date | 10-28-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.92 | ★ 157.89 |
| EPS | ★ 3.17 | 0.37 |
| Revenue | N/A | N/A |
| Revenue This Year | $8.06 | $4.53 |
| Revenue Next Year | $6.91 | $9.13 |
| P/E Ratio | ★ $42.96 | $52.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $85.10 | $9.99 |
| 52 Week High | $157.69 | $21.18 |
| Indicator | KEX | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 49.28 | 50.96 |
| Support Level | $128.37 | $16.59 |
| Resistance Level | $141.18 | $20.98 |
| Average True Range (ATR) | 3.02 | 0.60 |
| MACD | 0.22 | -0.17 |
| Stochastic Oscillator | 55.39 | 31.13 |
Kirby Corp is a domestic tank barge operator, transporting bulk liquid products throughout three United States coasts. The Company transports petrochemicals, liquid cargoes, inland waterway systems, and dry bulk cargoes. The Company conducts operations in two reportable business segments: The Marine transportation segment which provides marine transportation services, operating tank barges and towing vessels transporting bulk liquid products, and the Distribution and services segment, which provides after-market service, and genuine replacement parts for engines, transmissions, reduction gears, and power generation equipment used in oil and gas and commercial and industrial applications. The company's majority revenue is generated from the Marine Transportation segment.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.